Per May 2026 Type C meeting, AXPAXLI NDA for wet AMD to be based on SOL-1 Week 52 efficacy and safety plus interim SOL-R safety dataOcular to ...

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

The Pakistan Institute of Medical Sciences (PIMS) on Monday confirmed that the imprisoned founder of Pakistan Tehreek-e-Insaf Imran Khan underwent a scheduled eye procedure on Sunday, describing the ...

A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years, according to ...

A novel intravitreal axitinib hydrogel demonstrated durable disease control in patients with treatment-naive neovascular age-related macular degeneration (AMD), with superior maintenance of visual ...

Practicing ophthalmologists have an amazing legacy of catalyzing innovation to enhance our ability to retain, restore and ...

Regulatory clearance adds a 1,400-mg subcutaneous CD38 antibody option using CirCLIQ on-body delivery or provider-administered injection, maintaining the same active medicine as the IV formulation.

4FRONT-1, the first 4D-150 wet AMD phase 3 trial, is being conducted in North America in treatment-naïve patients with an ...

Glucagon-like peptide-1 (GLP-1) receptor agonists and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists help manage blood sugar in type 2 diabetes. They may also support ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Steroids, specifically corticosteroids, work by reducing inflammation that puts pressure on nerves and causes back pain. They lower levels of prostaglandins and other chemicals involved in the ...